Nutrien (NTR) Tops Q4 EPS by 17c

Nutrien (NYSE: NTR) reported Q4 EPS of $2.47, $0.17 better than the analyst estimate of $2.30. Revenue for the quarter came in at $0 versus the consensus estimate of $6.46 billion.

GUIDANCE:

Nutrien sees FY2022 EPS of $10.20-$11.80, versus the consensus of $9.56.

For earnings history and earnings-related data on Nutrien (NTR) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c